中文Schreiner MediPharm has received the Group Award for Innovation at the Finat Label Competition 2026 for a groundbreaking security seal that integrates digital authentication technology into pharmaceutical secondary packaging. The award recognizes a solution that addresses one of the most critical challenges in the global pharmaceutical supply chain: verifying product authenticity and detecting tampering in real time using nothing more than a standard smartphone.
The innovation arrives at a moment when pharmaceutical counterfeiting has reached alarming proportions. The World Health Organization estimates that counterfeit medicines account for a significant share of pharmaceuticals in developing markets, and even in regulated markets, the risk of tampering and illegal product substitution remains a persistent threat. Brand owners, regulators, and supply chain partners need tools that can verify authenticity at any point in the distribution chain, without specialized equipment or laboratory testing.
Schreiner’s security seal combines three layers of protection in a single construction. First, a covert digital authentication feature based on Cryptoglyph technology from Swiss company AlpVision is printed with high precision in the seal’s transparent area, invisible to the human eye. Second, a first-opening indication provides clear evidence if the package has been opened and resealed. Third, a guilloche pattern serves as an overt authenticity feature that can be visually inspected without any technology.
The digital authentication layer is the most innovative element. Cryptoglyph technology uses microscopically printed patterns that can be captured and verified by a standard smartphone camera. When a stakeholder — whether a brand inspector, distributor, customs authority, or pharmacist — scans the seal with a smartphone app, the system instantly determines whether the product is authentic. If the seal has been tampered with and resealed using adhesive tape, the digital feature becomes unreadable, making tampering attempts immediately detectable.
The real-time verification capability transforms the security seal from a passive deterrent into an active monitoring tool. Verification data is available to the brand owner for fraud detection, geotracking, and market analysis, providing visibility into where and when products are being checked and flagging suspicious patterns that may indicate counterfeiting or diversion. This data stream is increasingly valuable as regulatory frameworks around pharmaceutical traceability tighten globally.
The seal fulfills the requirements of the EU Falsified Medicines Directive and DIN EN 16679:2014 for tamper-evident packaging, making it immediately deployable for pharmaceutical companies operating in the European market. Compliance with these standards is not optional — the Falsified Medicines Directive mandates tamper-evident features and unique identifiers on all prescription medicines sold in the EU, and solutions that exceed the minimum requirements provide brand owners with additional protection.
Beyond regulatory compliance, the seal addresses practical supply chain realities. Pharmaceutical distribution involves multiple handoffs — from manufacturer to distributor to pharmacy to patient — and each handoff represents a potential point of vulnerability. A security seal that can be verified by any stakeholder with a smartphone, at any point in the chain, closes a gap that traditional tamper-evident labels cannot address. Traditional seals tell you that something happened; Schreiner’s solution tells you what happened, when, and where.
The combination of overt and covert features is also strategically important. Overt features like guilloche patterns provide immediate visual reassurance to consumers and casual inspection, while covert digital features provide the robust authentication that authorities and brand owners need for serious investigations. This layered approach recognizes that different stakeholders have different verification needs and capabilities.
The Finat Label Competition is one of the most respected awards programs in the label industry, and the Innovation Award specifically recognizes solutions that push the boundaries of what labels can do. Schreiner MediPharm’s win reinforces the growing recognition that labels are not merely decorative or informational but are increasingly functional components of product security and supply chain integrity systems.
For pharmaceutical companies evaluating tamper-evident and authentication solutions, the Schreiner seal offers a compelling combination: regulatory compliance, smartphone-based verification, real-time data capture, and multi-layer protection in a single construction. As the pharmaceutical industry continues to grapple with the global counterfeiting threat, solutions that make authentication accessible to every stakeholder in the supply chain will become essential rather than optional.
The broader implications for the pharmaceutical packaging industry are significant. As digital authentication technology becomes more accessible and affordable, the argument for deploying it across all prescription medicines — not just high-value or high-risk products — becomes increasingly compelling. The marginal cost of adding a Cryptoglyph feature to an existing security seal is modest, particularly when amortized across high-volume pharmaceutical production. Yet the protection it provides extends throughout the supply chain, from the manufacturing line to the pharmacy counter to the patient’s hands.
The data dimension of the Schreiner solution also deserves attention. Every smartphone scan generates a data point — location, time, product identifier — that, when aggregated, creates a real-time map of product distribution and authentication activity. For brand owners, this data stream is invaluable for detecting counterfeiting patterns, identifying diversion, monitoring supply chain integrity, and demonstrating compliance with regulatory requirements. The ability to provide this data as part of a security seal solution — rather than as a separate track-and-trace system — simplifies the technology stack and reduces the total cost of anti-counterfeiting infrastructure. As the pharmaceutical industry moves toward greater supply chain transparency and digital integration, solutions that combine physical security with digital data capture will become the standard rather than the exception. Schreiner’s Finat award suggests that the industry is beginning to recognize and reward this integrated approach to packaging security.
Source: Labels & Labeling
